T2 Biosystems (NASDAQ:TTOO – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 14th. Individual interested in listening to the company’s earnings conference call can do so using this link.
T2 Biosystems Price Performance
TTOO opened at $0.68 on Thursday. The business has a 50 day moving average of $1.86 and a 200-day moving average of $3.61. T2 Biosystems has a 1-year low of $0.63 and a 1-year high of $8.38.
Wall Street Analyst Weigh In
Several research firms have issued reports on TTOO. Canaccord Genuity Group raised their price target on shares of T2 Biosystems from $3.00 to $5.00 and gave the stock a “hold” rating in a research report on Tuesday, July 30th. StockNews.com upgraded T2 Biosystems to a “sell” rating in a research note on Tuesday, July 30th.
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Further Reading
- Five stocks we like better than T2 Biosystems
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- What a Trump Win Looks Like for the Market Now and Into 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Investing in the High PE Growth Stocks
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
